Cargando…
Emerging Therapeutic Targets Against Toxoplasma gondii: Update on DNA Repair Response Inhibitors and Genotoxic Drugs
Toxoplasma gondii is the causative agent of toxoplasmosis in animals and humans. This infection is transmitted to humans through oocysts released in the feces of the felines into the environment or by ingestion of undercooked meat. This implies that toxoplasmosis is a zoonotic disease and T. gondii...
Autores principales: | Angel, Sergio O., Vanagas, Laura, Ruiz, Diego M., Cristaldi, Constanza, Saldarriaga Cartagena, Ana M., Sullivan, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325978/ https://www.ncbi.nlm.nih.gov/pubmed/32656097 http://dx.doi.org/10.3389/fcimb.2020.00289 |
Ejemplares similares
-
Evaluation of ATM Kinase Inhibitor KU-55933 as Potential Anti-Toxoplasma gondii Agent
por: Munera López, Jonathan, et al.
Publicado: (2019) -
Modulation of autophagy as a therapeutic strategy for Toxoplasma gondii infection
por: Cheng, Ao, et al.
Publicado: (2022) -
Toxoplasma gondii Mechanisms of Entry Into Host Cells
por: Portes, Juliana, et al.
Publicado: (2020) -
Dynamics of Toxoplasma gondii Oocyst Phagocytosis by Macrophages
por: Ndao, Omar, et al.
Publicado: (2020) -
The Structural and Molecular Underpinnings of Gametogenesis in Toxoplasma gondii
por: Tomasina, Ramiro, et al.
Publicado: (2020)